Regulatory T cells-derived IL-35 promotes the growth of adult acute myeloid leukemia blasts

International Journal of Cancer

Volumn 137, Issue 10, 2015, Pages 2384-2393

  Tao, Qianshan ^a   Pan, Ying ^a   Wang, Yiping ^b   Wang, Huiping ^a   Xiong, Shudao ^a   Li, Qing ^a   Wang, Jia ^a   Tao, Lili ^a   Wang, Zhitao ^a   Wu, Fan ^a   Zhang, Rui ^a   Zhai, Zhimin ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

acute myeloid leukemia; IL 35; immune escape; regulatory T cells

Indexed keywords

INTERLEUKIN 35; CYTOKINE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, HUMAN;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TUMOR ESCAPE; TUMOR GROWTH; TUMOR PROMOTION; CELL PROLIFERATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL CULTURE;

ADULT; AGED; CELL PROLIFERATION; CYTOKINES; FEMALE; HUMANS; INTERLEUKINS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TUMOR CELLS, CULTURED; TUMOR ESCAPE;

EID: 84941944491     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29563     Document Type: Article

References (33)

1. Estey EH., Acute myeloid leukemia: 2013 update on risk-stratification and management. Am J Hematol 2013; 88: 318-27.
2. Szczepanski MJ, Szajnik M, Czystowska M, et al., Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia. Clin Cancer Res 2009; 15: 3325-32.
3. Ustun C, Miller JS, Munn DH, et al., Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation? Blood 2011; 118: 5084-95.
4. Yang W, Xu Y., Clinical significance of Treg cell frequency in acute myeloid leukemia. Int J Hematol 2013; 98: 558-62.
5. Wu H, Li P, Shao N, et al., Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-β in acute myeloid leukemia. Oncol Lett 2012; 3: 1119-23.
6. Zhou Q, Bucher C, Munger ME, et al., Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia. Blood 2009; 114: 3793-802.
7. Collison LW, Workman CJ, Kuo TT, et al., The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007; 450: 566-9.
8. Niedbala W, Wei XQ, Cai B, et al., IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007; 37: 3021-9.
9. Collison LW, Pillai MR, Chaturvedi V, et al., Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol 2009; 182: 6121-8.
10. + regulatory T cells do not constitutively express IL-35. J Immunol 2008; 181: 6898-905.
11. Chaturvedi V, Collison LW, Guy CS, et al., Cutting edge: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol 2011; 186: 6661-6.
12. + regulatory T cells are inhibited by CTLA-4 or IL-35 blockade. J Immunol 2012; 189: 5590-601.
13. Guttek K, Reinhold D., Stimulated human peripheral T cells produce high amounts of IL-35 protein in a proliferation-dependent manner. Cytokine 2013; 64: 46-50.
14. Vignali DA, Kuchroo VK., IL-12 family cytokines: immunological playmakers. Nat Immunol 2012; 13: 722-8.
15. Sakaguchi S, Yamaguchi T, Nomura T, et al., Regulatory T cells and immune tolerance. Cell 2008; 133: 775-87.
16. Wirtz S, Billmeier U, Mchedlidze T, et al., Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology 2011; 141: 1875-86.
17. Li X, Mai J, Virtue A, et al., IL-35 is a novel responsive anti-inflammatory cytokine-a new system of categorizing anti-inflammatory cytokines. PLoS One 2012; 7: e33628.
18. Collison LW, Chaturvedi V, Henderson AL, et al., IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 2010; 11: 1093-101.
19. Wang Z, Liu JQ, Liu Z, et al., Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis. J Immunol 2013; 190: 2415-23.
20. Zeng JC, Zhang Z, Li TY, et al., Assessing the role of IL-35 in colorectal cancer progression and prognosis. Int J Clin Exp Pathol 2013; 6: 1806-16.
21. Jin P, Ren H, Sun W, et al., Circulating IL-35 in pancreatic ductal adenocarcinoma patients. Hum Immunol 2014; 75: 29-33.
22. Trinchieri G., Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003. 3: 133-46.
23. Gavin MA, Rasmussen JP, Fontenot JD, et al., Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007; 445: 771-5.
24. Liu JQ, Liu Z, Zhang X, et al., Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis. J Immunol 2012; 188: 3099-106.
25. Nicholl MB, Ledgewood CL, Chen X, et al., IL-35 promotes pancreas cancer growth through enhancement of proliferation and inhibition of apoptosis: evidence for a role as an autocrine growth factor. Cytokine 2014; 70: 126-33.
26. Chaturvedi V, Collison LW, Guy CS, et al., Retraction: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol 2013; 191: 2018.
27. Allan SE, Song-Zhao GX, Abraham T, et al., Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur J Immunol 2008; 38: 3282-9.
28. Olson BM, Sullivan JA, Burlingham WJ., Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance. Front Immunol 2013; 4: 315.
29. Bachanova V, Cooley S, Defor TE, et al., Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein. Blood 2014; 123: 3855-63.
30. Collison LW, Delgoffe GM, Guy CS, et al., The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol 2012; 13: 290-9.
31. Ferretti E, Di Carlo E, Cocco C, et al., Direct inhibition of human acute myeloid leukemia cell growth by IL-12. Immunol Lett 2010; 133: 99-105.
32. Zorzoli A, Di Carlo E, Cocco C, et al., Interleukin-27 inhibits the growth of pediatric acute myeloid leukemia in NOD/SCID/Il2rg-/- mice. Clin Cancer Res 2012; 18: 1630-40.
33. Long J, Zhang X, Wen M, et al., IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells. Biochem Biophys Res Commun 2013; 430: 364-9.